Ultrahuman bags $70M from Qualcomm Ventures, Alpha Wave, and others

Bengaluru-based health intelligence firm Ultrahuman has secured $70 million in funding from various investors such as Qualcomm Ventures, Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria. This financing will be utilized to bolster research and development in areas like sensing, AI, miniaturized electronics, and health algorithms, while also intensifying investments in clinical science and extensive research.

The funding signifies the company's progression from a wearable health technology entity to a human-computer interface company with a focus on bodily aspects.

Ultrahuman's strategy revolves around crafting sensing technologies that closely interface with the human body to gather ongoing signals, subsequently linking these signals to intricate biological data. The firm intends to employ increasingly complex models, trained on empirical scientific data, to convert these signals into meaningful health insights.

Mohit Kumar, the Founder and CEO of Ultrahuman, highlighted the company's objective: "For an extended period, computers have comprehended virtually every facet of the world, save for the individual utilizing them. We intend to alter this landscape. We are constructing an interface capable of continuously comprehending the body and transforming its signals into beneficial intelligence for daily life."

The company's main offering is the Ultrahuman Ring, which integrates blood biomarkers, continuous glucose monitoring, environmental sensing, and a continually expanding software, AI, and research framework. These systems are engineered to construct a longitudinal perspective of human physiology rather than view health as disparate measurements.

Ultrahuman posits that wearable and body-based computing could emerge as a dominant computing platform within the ensuing decade, continuously tracking metrics such as sleep, cardiovascular health, metabolism, hormonal rhythms, blood biomarkers, recovery, and the surrounding environment. The aim is to harness these signals to furnish insights, enabling individuals to grasp and manage their health more effectively.

Quinn Li, Senior Vice President, Qualcomm Technologies, Inc., and global head of Qualcomm Ventures, commented on the significance of the investment: "The future of AI is personal, ambient, and always on." He expressed Ultrahuman's pioneering role in ushering a new era of personal AI devices that deliver personalized insights effortlessly. Li reaffirmed the company's support for Ultrahuman's journey as it broadens the horizons of personal AI devices.